Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies

被引:0
|
作者
Steven L Barriere
Martin E Stryjewski
G Ralph Corey
Fredric C Genter
Ethan Rubinstein
机构
[1] Theravance,Duke Clinical Research Institute and Department of Medicine, Division of Infectious Diseases
[2] Inc,Section of Infectious Diseases, Department of Internal Medicine and Medical Microbiology
[3] Centro de Educación Médica e Investigaciones Clinicas (CEMIC) Norberto Quirno,undefined
[4] Duke University Medical Center,undefined
[5] University of Manitoba,undefined
来源
关键词
Vancomycin; Trough levels; Nosocomial pneumonia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 41 条
  • [21] EFFECT OF BASELINE SERUM CRP LEVELS ON CLINICAL EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH FILGOTINIB: POST-HOC ANALYSIS FROM TWO PHASE 2B STUDIES
    Westhovens, R.
    Kavanaugh, A.
    Jamoul, C.
    Tasset, C.
    Harrison, P.
    Van der Aa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 148 - 148
  • [22] Clinical Outcomes of Filgotinib in Patients with RA Aged ≥65 Years: A Post Hoc Subgroup Analysis of Phase 2 and 3 Clinical Trials and Ongoing Long-Term Extensions
    Buch, Maya
    Combe, Bernard
    Gomez-Puerta, Jose A.
    Caporali, Roberto Felice
    Gottenberg, Jacques-Eric
    Van Hoek, Paul
    Rajendran, Vijay
    Stiers, Pieter-Jan
    Van Beneden, Katrien
    Aletaha, Daniel
    Burmester, Gerd
    Westhovens, Rene
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 538 - 541
  • [23] Effect of pegloticase on renal function in patients with chronic kidney disease: A post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials
    Yood R.A.
    Ottery F.D.
    Irish W.
    Wolfson M.
    BMC Research Notes, 7 (1)
  • [24] Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Helliwell, Philip
    Bushmakin, Andrew
    Gladman, Dafna
    FitzGerald, Oliver
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies
    Di Marco, Tobias
    Djonlagic, Ina
    Dauvilliers, Yves
    Sadeghi, Kolia
    Little, David
    Datta, Alexandre N.
    Hubbard, Jeffrey
    Hajak, Goeran
    Krystal, Andrew
    Olivieri, Antonio
    Parrino, Liborio
    Puryear, Corey B.
    Zammit, Gary
    Donoghue, Jacob
    Scammell, Thomas E.
    SLEEP, 2024,
  • [26] CLINICAL OUTCOMES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AGED ≥65 YEARS: A POST HOC SUBGROUP ANALYSIS OF PHASE 2 AND 3 CLINICAL TRIALS AND ONGOING LONG-TERM EXTENSIONS
    Buch, Maya H.
    Combe, Bernard
    Gomez-Puerta, Jose A.
    Caporali, Roberto
    Gottenberg, Jacques-Eric
    Van Hoek, Paul
    Rajendran, Vijay
    Stiers, Pieter-Jan
    Van Beneden, Katrien
    Aletaha, Daniel
    Burmester, Gerd
    Westhovens, Rene
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2023, 62
  • [27] The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
    Clifton O. Bingham
    David Walker
    Peter Nash
    Susan J. Lee
    Lei Ye
    Hao Hu
    Javaria Mona Khalid
    Bernard Combe
    Arthritis Research & Therapy, 24
  • [28] Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Coates, Laura
    Bushmakin, Andrew
    FitzGerald, Oliver
    Gladman, Dafna
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Helliwell, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [29] The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
    Bingham, Clifton O., III
    Walker, David
    Nash, Peter
    Lee, Susan J.
    Ye, Lei
    Hu, Hao
    Khalid, Javaria Mona
    Combe, Bernard
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [30] The Role of ADAMTS13 Activity Levels on Disease Exacerbation or Relapse in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of the Phase 3 HERCULES and Post-HERCULES Studies
    Strebel, Johanna A. Kremer Hovinga
    de la Rubia, Javier
    Pavenski, Katerina
    Metjian, Ara
    Knoebl, Paul
    Peyvandi, Flora
    Cataland, Spero
    Coppo, Paul
    Khan, Umer
    Menapace, Laurel A.
    Marques, Ana Paula
    Gunawardena, Sriya
    Scully, Marie
    BLOOD, 2022, 140 : 5651 - 5653